Clinical versus research genomics in kidney disease,Nature Reviews Nephrology

当前位置： X-MOL 学术 › Nat. Rev. Nephrol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical versus research genomics in kidney disease
Nature Reviews Nephrology ( IF 41.5 ) Pub Date : 2021-05-06 , DOI: 10.1038/s41581-021-00436-0
Andrew J Mallett _{1,

2,

3,

4} , Nine Knoers ₅ , John Sayer _{6,

7,

8} , Zornitza Stark _{4,

9,

10}

Affiliation

Department of Renal Medicine, Townsville University Hospital, Townsville, Australia.
College of Medicine and Dentistry, James Cook University, Townsville, Australia.
Institute for Molecular Bioscience and Faculty of Medicine, The University of Queensland, Brisbane, Australia.
KidGen Collaborative, Australian Genomics Health Alliance, Melbourne, Australia.
Department of Genetics, University Medical Centre Groningen, Groningen, Netherlands.
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Renal Services, The Newcastle Upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK.
National Institute for Health Research Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK.
Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Key differences exist between clinical and research genomics. As genomic testing is adopted in nephrology clinical care, we propose focusing on clinical genomics approaches to obtain genetic diagnoses in order to ensure optimal use of resources and maximum patient benefit.

中文翻译：